These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3145064)

  • 1. Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.
    Vora JP; Owens DR; Dolben J; Atiea JA; Dean JD; Kang S; Burch A; Brange J
    BMJ; 1988 Nov; 297(6658):1236-9. PubMed ID: 3145064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):942-8. PubMed ID: 1797506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.
    Jørgensen S; Vaag A; Langkjaer L; Hougaard P; Markussen J
    BMJ; 1989 Aug; 299(6696):415-9. PubMed ID: 2506998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects.
    Kang S; Creagh FM; Peters JR; Brange J; Vølund A; Owens DR
    Diabetes Care; 1991 Jul; 14(7):571-7. PubMed ID: 1914797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of insulin analogue B9AspB27Glu and soluble human insulin in insulin-treated diabetes.
    Kang S; Owens DR; Vora JP; Brange J
    Lancet; 1990 Feb; 335(8685):303-6. PubMed ID: 1967767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men: comparison with NPH insulin and the influence of different subcutaneous injection sites.
    Owens DR; Coates PA; Luzio SD; Tinbergen JP; Kurzhals R
    Diabetes Care; 2000 Jun; 23(6):813-9. PubMed ID: 10841002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action profile of the rapid acting insulin analogue: human insulin B28Asp.
    Heinemann L; Heise T; Jorgensen LN; Starke AA
    Diabet Med; 1993 Jul; 10(6):535-9. PubMed ID: 8365089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic model for the absorption of subcutaneously injected soluble insulin and monomeric insulin analogues.
    Trajanoski Z; Wach P; Kotanko P; Ott A; Skraba F
    Biomed Tech (Berl); 1993 Sep; 38(9):224-31. PubMed ID: 8218870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of circulating epinephrine on absorption of subcutaneously injected insulin.
    Fernqvist E; Gunnarsson R; Linde B
    Diabetes; 1988 Jun; 37(6):694-701. PubMed ID: 3289990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.
    Luzio SD; Beck P; Owens DR
    Horm Metab Res; 2003 Jul; 35(7):434-8. PubMed ID: 12931275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.
    Nielsen FS; Jørgensen LN; Ipsen M; Voldsgaard AI; Parving HH
    Diabetologia; 1995 May; 38(5):592-8. PubMed ID: 7489843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular versus subcutaneous injection of soluble and lispro insulin: comparison of metabolic effects in healthy subjects.
    Rave K; Heise T; Weyer C; Herrnberger J; Bender R; Hirschberger S; Heinemann L
    Diabet Med; 1998 Sep; 15(9):747-51. PubMed ID: 9737803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble and Lente human insulin mixtures in normal man.
    Owens DR; Vora JP; Jones IR; Birtwell J; Atiea J; Luzio S; Williams S
    Diabetes Res; 1988 Jan; 7(1):35-40. PubMed ID: 3042252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically important differences in insulin absorption from abdomen in IDDM.
    Frid A; Linde B
    Diabetes Res Clin Pract; 1993; 21(2-3):137-41. PubMed ID: 8269814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of aprotinin on regional absorption of soluble human insulin.
    Owens DR; Vora JP; Birtwell J; Luzio S; Hayes TM
    Br J Clin Pharmacol; 1988 Apr; 25(4):453-6. PubMed ID: 2454647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of subcutaneously administered soluble insulin and des-(B26-B30)-insulin-B25-amide in rabbit, pig and healthy man.
    Hartmann H; Moesus E; Creutzfeldt W
    Diabetes Res Clin Pract; 1992 Jun; 16(3):175-81. PubMed ID: 1425137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin bolus given by sprinkler needle: effect on absorption and glycaemic response to a meal.
    Edsberg B; Herly D; Hildebrandt P; Kühl C
    Br Med J (Clin Res Ed); 1987 May; 294(6584):1373-6. PubMed ID: 3109661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry.
    Vora JP; Burch A; Peters JR; Owens DR
    Diabetes Care; 1992 Nov; 15(11):1484-93. PubMed ID: 1334825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption of radiolabelled soluble insulin in type 1 (insulin-dependent) diabetes: influence of subcutaneous blood flow and anthropometry.
    Vora JP; Burch A; Peters JR; Owens DR
    Diabet Med; 1993 Oct; 10(8):736-43. PubMed ID: 8261756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.